Herbion Bršljan

Herbion Bršljan is a herbal product containing a dry extract of Hederae folium (ivy leaf) prepared with 30% ethanol, supplied in oral dosage form. The extract is standardized at a ratio of 5‑7.5:1, meaning 5‑7.5 g of raw leaf yields 1 g of dry extract. It is marketed in the European Union and classified as an unscheduled herbal supplement. The product is intended for oral intake and is distributed without a prescription.

Herbion Bršljan is traditionally used as a supportive herbal preparation for respiratory health. While clinical evidence is limited, the ivy leaf extract is commonly associated with the following applications:

- Support of normal bronchial function and airway tone. - Adjunctive use in occasional dry or productive cough. - Assistance with mucus clearance through gentle expectorant activity. - Potential soothing of throat irritation associated with mild inflammation. - Use as part of herbal regimens for seasonal respiratory discomfort and mild bronchospasm. - May be incorporated in complementary approaches for mild upper‑airway congestion during cold weather.

Adverse reactions to oral ivy leaf extract are generally uncommon, but they have been reported in clinical observations and post‑marketing surveillance.

Common: - Gastrointestinal discomfort such as nausea or abdominal cramps. - Mild headache. - Transient skin rash or pruritus. - Increased salivation. - Dizziness or light‑headed feeling. - Taste disturbance or metallic aftertaste. - Mild insomnia or sleep disturbance. - Temporary increase in bowel movements. - Transient visual disturbances such as blurred vision. - Minor swelling of the lips or tongue.

Serious: - Allergic anaphylactic reaction with difficulty breathing. - Severe bronchospasm worsening respiratory symptoms. - Hepatotoxicity indicated by elevated liver enzymes (rare). - Severe gastrointestinal bleeding (very rare). - Cardiovascular effects such as tachycardia (rare). - Renal impairment manifested by decreased urine output (rare). - Blood pressure fluctuations, either hypotension or hypertension (rare).

When considering Herbion Bršljan, certain precautionary measures should be observed to minimize risk and ensure appropriate use.

- Not recommended for individuals with known hypersensitivity to ivy or related plants. - Caution in pregnant or breastfeeding women due to lack of safety data. - Avoid use in children under a certain age without medical advice. - Monitor for signs of allergic reaction, especially after first administration. - Discontinue if gastrointestinal or respiratory symptoms worsen. - Consult a healthcare professional before combining with other herbal or prescription cough remedies.

Herbion Bršljan may interact with certain medications or other herbal products; awareness of these potential interactions helps to avoid adverse outcomes.

Avoid: - Concurrent use with potent bronchodilators or antitussive agents without medical supervision (risk of additive respiratory effects). - Combination with anticoagulant or antiplatelet drugs (possible increased bleeding risk). - Avoid simultaneous use with herbal expectorants containing high levels of mucolytic agents (risk of excessive mucus production).

Use with caution: - Co‑administration with other saponin‑containing herbs (may enhance gastrointestinal irritation). - Use alongside sedatives or CNS depressants (potential additive drowsiness). - Concurrent intake with medications metabolized by CYP450 enzymes (possible alteration of drug levels). - Use with caution in patients taking antihypertensive drugs (ivy may have mild vasodilatory effects).